Plus Therapeutics (PSTV) Asset Writedowns and Impairment (2010 - 2015)
Plus Therapeutics (PSTV) reported Asset Writedowns and Impairment of -$105000.0 for Q4 2015, down 150.0% year-over-year from $210000.0 in Q4 2014, and down 150.0% quarter-over-quarter from -$42000.0 in Q4 2014.
Plus Therapeutics (PSTV) Asset Writedowns and Impairment (2010 - 2015) Analysis & Trends
Plus Therapeutics (PSTV) has 6 years of Asset Writedowns and Impairment data on file, last reported at -$105000.0 in Q4 2015.
- Asset Writedowns and Impairment for Q4 2015 came in at -$105000.0, down 150.0% year-over-year; the trailing twelve-month figure through Dec 2015 was -$105000.0 (down 109.69% YoY), and the FY2020 annual result was $107000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment eased to -$105000.0 in Q4 2015 per PSTV's latest filing, from -$42000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $750000.0 in Q3 2013 and troughed at -$105000.0 in Q4 2015.
- A 5-year average of $161588.2 and a median of $87000.0 in 2013 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2012 and 2013: Asset Writedowns and Impairment slumped 214.29% in 2012, then surged 837.5% in 2013.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $209000.0 in 2011, then plunged by 78.47% to $45000.0 in 2012, then soared by 351.11% to $203000.0 in 2013, then slumped by 120.69% to -$42000.0 in 2014, then sank by 150.0% to -$105000.0 in 2015.
- Business Quant data shows PSTV's Asset Writedowns and Impairment at -$105000.0 in Q4 2015, -$42000.0 in Q4 2014, and $290000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -105,000.00 |
| Dec 31, 2015 | -105,000.00 |
| Dec 31, 2014 | -42,000.00 |
| Dec 31, 2014 | -42,000.00 |
| Sep 30, 2014 | 290,000.00 |
| Sep 30, 2014 | 290,000.00 |
| Jun 30, 2014 | 371,000.00 |
| Jun 30, 2014 | 371,000.00 |
| Mar 31, 2014 | 465,000.00 |
| Mar 31, 2014 | 465,000.00 |
| Dec 31, 2013 | 203,000.00 |
| Dec 31, 2013 | 203,000.00 |
| Sep 30, 2013 | 750,000.00 |
| Sep 30, 2013 | 750,000.00 |
| Jun 30, 2013 | 101,000.00 |
| Jun 30, 2013 | 101,000.00 |
| Mar 31, 2013 | 87,000.00 |
| Mar 31, 2013 | 87,000.00 |
| Dec 31, 2012 | 45,000.00 |
| Dec 31, 2012 | 45,000.00 |